Article
Genetic and molecular targets in lymphoma: implications for prognosis and treatment.
Future oncology (London, England) - 1 Dec 2014
Bachegowda Lohith S, Barta Stefan K
Abstract excerpt
Lymphomas are the most common hematologic malignancies with approximately 79,000 new cases estimated for 2013 in the USA. Despite improved outcomes, relapse or recurrence remains a common problem with conventional cytotoxic therapy. Recently, many genetic and molecular mechanisms that drive various cellular events like apoptosis, angiogenesis and cell motility have been more clearly delineated. These new...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
